Stem cell therapy for recent stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a patient's own bone marrow stem cells can help improve recovery after a moderate-to-severe ischemic stroke that happened 3 to 12 months ago.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You had a moderate-to-severe ischemic stroke 3 to 12 months ago
- You are able to walk or move with some help (disability level 3-5 on the Modified Rankin Scale)
- You are not on blood thinners or steroids
- You do not have a current infection, cancer, or serious organ problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether umbilical cord stem cells given through a vein can help people recovering from a recent stroke. It is for patients with moderate arm or leg weakness.
This study tests whether a nasal spray containing tiny particles from donated stem cells can help people recover from a recent ischemic stroke. The treatment is given as a nose spray, and you will be monitored for up to 14 days after your stroke.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This trial tests whether umbilical cord stem cells given within a month after a stroke can help patients recover. It is for people with a moderate to moderately severe stroke affecting the front part of the brain.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.